Gene · 5136
Papers484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic overlap between estimated glomerular filtration rate and cardiovascular disease identifies potential targets for cardiorenal syndrome. | Ren Fail | 2026 | 42661344 | PubTator, text mining | PubMed |
| Citraconate preserves T cell stemness and antitumor immunity. | Sci Immunol | 2026 | 42066062 | PubTator, text mining | PubMed |
| Network pharmacology and integrative bioinformatics analyses identify PDE1A as a key target of pirfenidone in idiopathic pulmonary fibrosis. | PLoS One | 2026 | 41961843 | PubTator, text mining | PubMed |
| Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer. | Oncol Res | 2026 | 41799512 | PubTator, text mining | PubMed |
| Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. | Medicine (Baltimore) | 2026 | 41790675 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
| Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential. | Bone Rep | 2026 | 41732176 | PubTator, text mining | PubMed |
| PDE1A: A novel actionable therapeutic target for progressive chronic kidney disease. | Mol Ther | 2026 | 41713423 | PubTator, text mining | PubMed |
| Integrating the Data From Microbiome and Metabolome Genome-Wide Association Studies to Uncover Gene-Microbe-Metabolite Interactions in Allergic Diseases. | Cureus | 2025 | 41561239 | PubTator, text mining | PubMed |
| Cyclic nucleotide phosphodiesterase 1 and cognitive impairment: Mechanistic insights and therapeutic implications. | Biomed Pharmacother | 2025 | 41273928 | PubTator, text mining | PubMed |
| The Molecular Mechanism of PDE1 Regulation. | Cells | 2025 | 41227367 | PubTator, text mining | PubMed |
| NGS Approaches in Clinical Diagnostics: From Workflow to Disease-Specific Applications. | Int J Mol Sci | 2025 | 41096862 | PubTator, text mining | PubMed |
| A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding. | Commun Med (Lond) | 2025 | 40739398 | PubTator, text mining | PubMed |
| Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer. | Elife | 2025 | 40704992 | PubTator, text mining | PubMed |
| miRNAome-metabolome wide association study reveals effects of miRNA regulation in male diabetic erectile dysfunction. | Free Radic Biol Med | 2025 | 40618911 | PubTator, text mining | PubMed |
| Editorial: High-throughput sequencing-based investigation of chronic disease markers and mechanisms, volume II. | Front Genet | 2025 | 40510812 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection? | Neural Regen Res | 2025 | 39104101 | PubTator, text mining | PubMed |
| Development of a Candidate 11C‑Labeled Selective Phosphodiesterase 1 Radioligand for Positron Emission Tomography. | ACS Omega | 2024 | 39524622 | PubTator, text mining | PubMed |
| Mapping the glial transcriptome in Huntington's disease using snRNAseq: selective disruption of glial signatures across brain regions. | Acta Neuropathol Commun | 2024 | 39428482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5136/papers